Zobrazeno 1 - 10
of 2 962
pro vyhledávání: '"11"'
Autor:
Alexa J. Siddon, Thomas Prebet, Scott F. Huntington, Jan Philipp Bewersdorf, Stephanie Halene, Francine M. Foss, Noffar Bar, Natalia Neparidze, Amer M. Zeidan, Rory M. Shallis, Iris Isufi, Terri L. Parker, Nikolai A. Podoltsev, Stuart Seropian, Tae Kon Kim, Manoj M. Pillai, Steven D. Gore, Autumn DiAdamo, Lohith Gowda
Publikováno v:
Blood. 134:5174-5174
Introduction: Isolated trisomy 11 is a rare, poorly characterized cytogenetic abnormality in myeloid neoplasms (MN) with only a few case series published. Prior reports suggested a lower response rate to standard treatments such as intensive chemothe
Autor:
Naohiro Tsuyama, Karnan Sivasundaram, Akira Sakai, Ichiro Hanamura, Megumi Sasatani, Tomonari Shigemura, Yusuke Azami, Yuko Hashimoto, Yu Abe, Yukari Yanai, Akinobu Ota, Aki Yanagi, Misaki Sugai, Masafumi Onodera, Moe Muramatsu, Takayuki Ikezoe, Kenji Kamiya
Publikováno v:
Blood. 134:3057-3057
The cellular origin of multiple myeloma (MM) has not ben identified. Based on the results of transplantation experiments using bone marrow samples from MM patients in immunodeficient mice, so-called myeloma stem cells have been inferred to be present
Publikováno v:
Blood. 110:4997-4997
Interleukin 11 (IL11) has been approved for clinical utilization by Chinese Drug and Food Administration in the treatment of thrombopenia post chemo/radio therapy. It has been proved a safe cytokine in previous clinical trials. We however found a cas
Publikováno v:
Blood. 80:3189-3197
A frequent site for nonrandom recombination in T-cell acute lymphoblastic leukemia (T-ALL) is chromosome 11 at p13. The molecular characterization of a (7;11)(q35;p13) translocation showed that the translocation breakpoint was 2 kb 5′ to the T-ALLb
Autor:
Michael Andreeff, Peter McLaughlin, Yang Huh, Andreas H. Sarris, Ugo Consoli, Susan Starry, Alma Rodriguez, Fernando Cabanillas, Anas Younes
Publikováno v:
Blood. 87:1698-1703
The growth stimulatory effects of interleukin-3 (IL-3) on normal hematopoietic progenitor cells are well established, and clinical trials using IL-3 after bone marrow transplantation for various malignancies including lymphomas are frequently conduct
Publikováno v:
Blood. 95:1872-1874
Granulocyte colony-stimulating factor (G-CSF) can effectively mobilize hematopoietic stem and progenitor cells from bone marrow into blood, thereby allowing peripheral blood stem cells (PBSCs) to be used for transplantation. The efficiency of PBSC mo
Autor:
Jeffrey M. Weinberg, Bernice M. Benoit, Christine Jaworsky, Alain H. Rook, Stuart R. Lessin, Brett Telegan
Publikováno v:
Blood. 86:4257-4262
EZARY CELLS are lymphocytes with hyperconvoluted or cerebriform nuclear contours. Morphologically, they are characterized by a high nucleus-to-cytoplasm ratio, deep and narrow nuclear indentations, condensed chromatin at the nuclear membrane, and cyt
Autor:
A M Smith, Linda M. Pilarski, P L Bergsagel, Michael J. Mant, Andrew R. Belch, Agnieszka J. Szczepek
Publikováno v:
Blood. 85:436-447
Multiple myeloma (MM) is characterized by a plasma cell infiltrate of the bone marrow (BM). However, late-stage monotypic B cells have been detected in the blood. This work analyzes the effects of clinical treatment on late stage CD19+ B cells presen
Publikováno v:
Blood. 83:600-609
We investigated the ability of the macrolide antifungal agent rapamycin (RAPA) to inhibit the rejection of T-cell-depleted (TCD) donor bone marrow (BM) transplanted into major histocompatibility complex (MHC)- disparate irradiated recipients. RAPA (1
Publikováno v:
Blood. 81:935-941
Recently, a variety of growth factor-dependent subclones of the murine interleukin-3 (IL-3)-dependent cell line 32D have been isolated. These subclones include those dependent for growth on erythropoietin (Epo) (32D Epo), granulocyte-macrophage colon